ArticlePloS one2009
General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007.
Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Liver Injury by Statins in Coronary Heart Disease (CHD) Patients With History of Hepatitis B Virus (HBV) Infection
Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C: Multi-center, Prospective, Observational Real-world Study in EASTERN China
Who cites it
57 citing papers in PubMed.
- DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.BMC infectious diseases · 2019Trial
- The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012Trial
- Knowledge, attitude, and practices towards hepatitis infection and its associated factors among adults in Gondar town, northwest Ethiopia; a community-based study, 2021.Journal of health, population, and nutrition · 2024Article
- Elimination of hepatitis C in a hospital characterized by infectious diseases.Frontiers in public health · 2023Article
- Hepatitis C Virus Infection in Eastern Libya: Efforts Needed to Improve HCV Testing and Linkage to Care in the Resource-Limited Setting.Tropical medicine and infectious disease · 2022Article
- Prevalence of Viral Hepatitis B, C, and D in Kazakhstan.TheScientificWorldJournal · 2022Article
- HEV prevalence and potential risk factors in a large multi-ethnic youth cohort in China.Virology journal · 2021Article
- Observational
- Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study.Canadian journal of gastroenterology & hepatology · 2020Article
- Hepatitis C screening in hospitals: find the missing patients.Virology journal · 2019Article
- Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China.Open forum infectious diseases · 2019Article
- Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China.Journal of clinical and translational hepatology · 2018Article
- [Seroepidemiological investigation of hepatitis C virus in Zhejiang Province: a hospital-based study].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018Article
- Globalization and the Changing Epidemiology of Hepatitis A Virus.Cold Spring Harbor perspectives in medicine · 2018Review
- The impact of economic and social factors on the prevalence of hepatitis B in Turkey.BMC public health · 2018Article
- Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003-2015): Implications for Prevention and Control Policies.International journal of environmental research and public health · 2018Article
- Evaluation of candidate genes associated with hepatitis A and E virus infection in Chinese Han population.Virology journal · 2018Article
- Sharp instrument injuries among hospital healthcare workers in mainland China: a cross-sectional study.BMJ open · 2017Observational
- Aetiological characteristics of adult acute diarrhoea in a general hospital of Shanghai.Epidemiology and infection · 2017Article
- Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa.Infectious agents and cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundViral hepatitis is a serious health burden worldwide. To date, few reports have addressed the prevalence of hepatitis A, B, C, and E in China. Therefore, the general epidemiological parameters of viral hepatitis remain unknown. PRINCIPAL
findingsIn this cross-sectional study, we performed a serological prevalence analysis of viral hepatitis A, B, C, and E in 8,762 randomly selected Chinese subjects, which represented six areas of China. The overall prevalence of anti-Hepatitis C virus antibody (anti-HCV) was 0.58%, which was much lower than was estimated by WHO. The prevalences of Hepatitis B virus surface antigen (HBsAg), anti-Hepatitis B virus surface protein antibody (HBsAb), and anti-Hepatitis B virus core protein antibody (HBcAb) were 5.84%, 41.31%, and 35.92%, respectively, whereas in the group of subjects less than 5 years old, these prevalences were 1.16%, 46.77%, and 8.69% respectively, which suggests that the Hepatitis B virus (HBV)-carrier population is decreasing, and the nationwide HBV vaccine program has contributed to the lowered HBV prevalence in the younger generation in China. Meanwhile, a large deficit remains in coverage provided by the national HBV immune program. In addition, our data suggested the possibility that HBsAb may not last long enough to protect people from HBV infection throughout life. The overall prevalence of anti-Hepatitis A virus antibody (anti-HAV) and anti-Hepatitis E virus antibody (anti-HEV) were as high as 72.87% and 17.66%, respectively. The indices increased with age, which suggests that a large proportion of Chinese adults are protected by latent infection. Furthermore, the pattern of HEV infection was significantly different among ethnic groups in China.
conclusionsOur study provided much important information concerning hepatitis A, B, C, and E prevalence in China and will contribute to worldwide oversight of viral hepatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.